Istanbul Okan University, Faculty of Medicine, Department of General Surgery, Istanbul, Turkey.
Department of General Surgery, Baskent University Faculty of Medicine, Ankara, Turkey.
Transplant Proc. 2022 Jul-Aug;54(6):1417-1423. doi: 10.1016/j.transproceed.2021.12.001. Epub 2021 Dec 8.
Uncertainty raises questions in kidney transplant during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic regarding the recipient, the donor, and health care professionals. The pandemic not only has disrupted kidney transplanted patients but also has influenced transplant systems, donation chains, and timely and safe transplant surgeries. In the present study, we aimed to explore the global effects of the SARS-CoV-2 pandemic on kidney transplant.
We collected transplantation statistics and SARS-CoV-2 pandemic data from the World Health Organization website on June 15, 2021. Spearman correlation analysis was applied to assess the strength of a monotonic relationship among quantitative variables. We also demonstrated the clinical characteristics of our kidney recipients with SARS-CoV-2 infection.
Comparison of the mean of global kidney transplantation statistics between 2010 and 2019 with 2020 statistics showed a significant decrease in kidney transplant from living donors (P < .001). From the beginning of the pandemic to June 15, 2021, 1 of the 43 kidney transplant patients we treated in our clinic died of SARS-CoV-2 infection after discharge. Two of the patients we transplanted and saw in follow-up before the pandemic died of SARS-CoV-2 infection.
While the overall kidney transplant numbers have increased in the year to date, kidney transplants decreased drastically at the onset of the pandemic.
在严重急性呼吸综合征冠状病毒 2 （SARS-CoV-2）大流行期间，对于接受者、供体和医疗保健专业人员而言，不确定性引发了有关肾脏移植的问题。大流行不仅扰乱了肾移植患者，还影响了移植系统、捐赠链以及及时和安全的移植手术。在本研究中，我们旨在探讨 SARS-CoV-2 大流行对肾脏移植的全球影响。
我们于 2021 年 6 月 15 日从世界卫生组织网站收集了移植统计数据和 SARS-CoV-2 大流行数据。应用 Spearman 相关分析评估定量变量之间单调关系的强度。我们还展示了我们患有 SARS-CoV-2 感染的肾受者的临床特征。
与 2010 年至 2019 年的全球肾脏移植统计数据平均值相比，2020 年的肾脏移植统计数据显示来自活体供体的肾脏移植明显减少（P <.001）。从大流行开始到 2021 年 6 月 15 日，我们在诊所治疗的 43 例肾移植患者中有 1 例在出院后死于 SARS-CoV-2 感染。我们在大流行前移植并随访的 2 例患者死于 SARS-CoV-2 感染。
尽管今年的整体肾脏移植数量有所增加，但大流行开始时肾脏移植急剧下降。
